Skip to main content
Top
Published in: Netherlands Heart Journal 6/2017

Open Access 01-06-2017 | Original Article

Use of three-dimensional computed tomography overlay for real-time cryoballoon ablation in atrial fibrillation reduces radiation dose and contrast dye

Authors: B. Oude Velthuis, M. Molenaar, H. G. Reinhart Dorman, J. Y. Stevenhagen, M. F. Scholten, J. van der Palen, J. M. van Opstal

Published in: Netherlands Heart Journal | Issue 6/2017

Login to get access

Abstract

Aims

Cryoballoon pulmonary vein (PV) isolation in patients with atrial fibrillation has proven to be effective in short-term and long-term follow-up. To visualise the PV anatomy, pre-ablation contrast pulmonary venography is commonly performed. Three-dimensional (3D) computed tomography (CT) overlay is a new technique creating a live 3D image of the left atrium by integrating a previously obtained CT scan during fluoroscopy. To evaluate the benefits of 3D CT overlay during cryoballoon ablation, we studied the use of 3D CT overlay versus contrast pulmonary venography in a randomised fashion in patients with paroxysmal atrial fibrillation undergoing cryoballoon PV isolation.

Methods and results

Between October 2012 and June 2013, 30 patients accepted for PV isolation were randomised to cryoballoon PV isolation using either 3D CT overlay or contrast pulmonary venography. All patients underwent a pre-procedural cardiac CT for evaluation of the anatomy of the left atrium (LA) and the PVs. In the 3D CT overlay group, a 3D reconstruction of the LA and PVs was made. An overlay of the CT reconstruction was then projected over live fluoroscopy. Patients in the contrast pulmonary venography group received significantly more contrast agent (77.1 ± 21.2 cc vs 40.1 ± 17.6 cc, p < 0.001) and radiation (43.0 ± 21.9 Gy.cm2 vs 28.41 ± 11.7 Gy.cm2, p = 0.04) than subjects in the 3D CT overlay group. There was no difference in total procedure time, fluoroscopy time and the amount of cryoapplications between the two groups.

Conclusion

The use of 3D CT overlay decreases radiation and contrast dye exposure and can assist in guiding cryoballoon-based PV isolation.
Literature
1.
go back to reference Camm AJ, Lip GY, De CR, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719–47. Camm AJ, Lip GY, De CR, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association. Eur Heart J. 2012;33(21):2719–47.
2.
go back to reference Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659–66. Haissaguerre M, Jais P, Shah DC, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659–66.
3.
go back to reference Cosedis NJ, Johannessen A, Raatikainen P, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med. 2012;367(17):1587–95. Cosedis NJ, Johannessen A, Raatikainen P, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med. 2012;367(17):1587–95.
4.
go back to reference Jais P, Cauchemez B, Macle L, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008;118(24):2498–505. Jais P, Cauchemez B, Macle L, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008;118(24):2498–505.
5.
go back to reference Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303(4):333–40. Wilber DJ, Pappone C, Neuzil P, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303(4):333–40.
6.
go back to reference Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713–23. Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713–23.
7.
go back to reference Andrade JG, Khairy P, Guerra PG, et al. Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies. Heart Rhythm. 2011;8(9):1444–51. Andrade JG, Khairy P, Guerra PG, et al. Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies. Heart Rhythm. 2011;8(9):1444–51.
8.
go back to reference Kuck KH, Brugada J, Furnkranz A, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374(23):2235–45. Kuck KH, Brugada J, Furnkranz A, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374(23):2235–45.
9.
go back to reference Sarabanda AV, Bunch TJ, Johnson SB, et al. Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system. J Am Coll Cardiol. 2005;46(10):1902–12. Sarabanda AV, Bunch TJ, Johnson SB, et al. Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system. J Am Coll Cardiol. 2005;46(10):1902–12.
10.
go back to reference Schmidt M, Dorwarth U, Andresen D, et al. Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German ablation registry. J Cardiovasc Electrophysiol. 2014;25(1):1–7. Schmidt M, Dorwarth U, Andresen D, et al. Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: results from the German ablation registry. J Cardiovasc Electrophysiol. 2014;25(1):1–7.
11.
go back to reference Ottaviano L, Chierchia GB, Bregasi A, et al. Cryoballoon ablation for atrial fibrillation guided by real-time three-dimensional transoesophageal echocardiography: a feasibility study. Europace. 2013;15(7):944–50. Ottaviano L, Chierchia GB, Bregasi A, et al. Cryoballoon ablation for atrial fibrillation guided by real-time three-dimensional transoesophageal echocardiography: a feasibility study. Europace. 2013;15(7):944–50.
12.
go back to reference Stevenhagen J, Van Der Voort PH, Dekker LR, Bullens RW, Van Den Bosch H, Meijer A. Three-dimensional CT overlay in comparison to CartoMerge for pulmonary vein antrum isolation. J Cardiovasc Electrophysiol. 2010;21(6):634–9. Stevenhagen J, Van Der Voort PH, Dekker LR, Bullens RW, Van Den Bosch H, Meijer A. Three-dimensional CT overlay in comparison to CartoMerge for pulmonary vein antrum isolation. J Cardiovasc Electrophysiol. 2010;21(6):634–9.
13.
go back to reference Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360–420. Camm AJ, Kirchhof P, Lip GY, et al. Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Europace. 2010;12(10):1360–420.
14.
go back to reference Oude VB, Stevenhagen J, van Opstal JM, Scholten MF. Continuation of vitamin K antagonists as acceptable anticoagulation regimen in patients undergoing pulmonary vein isolation. Neth Heart J. 2012;20(1):12–5. Oude VB, Stevenhagen J, van Opstal JM, Scholten MF. Continuation of vitamin K antagonists as acceptable anticoagulation regimen in patients undergoing pulmonary vein isolation. Neth Heart J. 2012;20(1):12–5.
15.
go back to reference Andrade JG, Dubuc M, Guerra PG,et al. Pulmonary vein isolation using a second-generation cryoballoon catheter: a randomized comparison of ablation duration and method of deflation. J Cardiovasc Electrophysiol. 2013;24(6):692–8. Andrade JG, Dubuc M, Guerra PG,et al. Pulmonary vein isolation using a second-generation cryoballoon catheter: a randomized comparison of ablation duration and method of deflation. J Cardiovasc Electrophysiol. 2013;24(6):692–8.
16.
go back to reference Schultz FW, Zoetelief J. Dose conversion coefficients for interventional procedures. Radiat Prot Dosimetry. 2005;117(1–3):225–30.PubMed Schultz FW, Zoetelief J. Dose conversion coefficients for interventional procedures. Radiat Prot Dosimetry. 2005;117(1–3):225–30.PubMed
17.
go back to reference Karaarslan E, Ulus S, Bavbek C. Estimated radiation dose and image quality comparison of the scan protocols in dual-source computed tomography coronary angiography. J Med Imaging Radiat Oncol. 2013;57(4):407–14.CrossRefPubMed Karaarslan E, Ulus S, Bavbek C. Estimated radiation dose and image quality comparison of the scan protocols in dual-source computed tomography coronary angiography. J Med Imaging Radiat Oncol. 2013;57(4):407–14.CrossRefPubMed
18.
go back to reference Ector J, Dragusin O, Adriaenssens B, et al. Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation. J Am Coll Cardiol. 2007;50(3):234–42. Ector J, Dragusin O, Adriaenssens B, et al. Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation. J Am Coll Cardiol. 2007;50(3):234–42.
19.
go back to reference Muller A, Scharner W, Borchardt T, Och W, Korb H. Reliability of an external loop recorder for automatic recognition and transtelephonic ECG transmission of atrial fibrillation. J Telemed Telecare. 2009;15(8):391–6.CrossRefPubMed Muller A, Scharner W, Borchardt T, Och W, Korb H. Reliability of an external loop recorder for automatic recognition and transtelephonic ECG transmission of atrial fibrillation. J Telemed Telecare. 2009;15(8):391–6.CrossRefPubMed
20.
go back to reference Velthuis BO, Bos J, Kraaier K, et al. Performance of an external transtelephonic loop recorder for automated detection of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol. 2013;18(6):564–70. Velthuis BO, Bos J, Kraaier K, et al. Performance of an external transtelephonic loop recorder for automated detection of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol. 2013;18(6):564–70.
21.
go back to reference Molenaar MMD, Scholten MF, Hesselink T, Stevenhagen YJ, van Opstal JM. High incidence of low esophageal temperatures during cryoballoon therapy for atrial fibrillation. HRS Boston, Ref Type: Abstract, 8‑1-2014. 2014. Molenaar MMD, Scholten MF, Hesselink T, Stevenhagen YJ, van Opstal JM. High incidence of low esophageal temperatures during cryoballoon therapy for atrial fibrillation. HRS Boston, Ref Type: Abstract, 8‑1-2014. 2014.
22.
23.
go back to reference Kuwahara T, Takahashi A, Takahashi Y, et al. Clinical characteristics and management of periesophageal vagal nerve injury complicating left atrial ablation of atrial fibrillation: lessons from eleven cases. J Cardiovasc Electrophysiol. 2013;24(8):847–51. Kuwahara T, Takahashi A, Takahashi Y, et al. Clinical characteristics and management of periesophageal vagal nerve injury complicating left atrial ablation of atrial fibrillation: lessons from eleven cases. J Cardiovasc Electrophysiol. 2013;24(8):847–51.
24.
go back to reference Metzner A, Burchard A, Wohlmuth P, et al. Increased incidence of esophageal thermal lesions using the second-generation 28-mm cryoballoon. Circ Arrhythm Electrophysiol. 2013;6(4):769–75. Metzner A, Burchard A, Wohlmuth P, et al. Increased incidence of esophageal thermal lesions using the second-generation 28-mm cryoballoon. Circ Arrhythm Electrophysiol. 2013;6(4):769–75.
Metadata
Title
Use of three-dimensional computed tomography overlay for real-time cryoballoon ablation in atrial fibrillation reduces radiation dose and contrast dye
Authors
B. Oude Velthuis
M. Molenaar
H. G. Reinhart Dorman
J. Y. Stevenhagen
M. F. Scholten
J. van der Palen
J. M. van Opstal
Publication date
01-06-2017
Publisher
Bohn Stafleu van Loghum
Published in
Netherlands Heart Journal / Issue 6/2017
Print ISSN: 1568-5888
Electronic ISSN: 1876-6250
DOI
https://doi.org/10.1007/s12471-017-0962-7

Other articles of this Issue 6/2017

Netherlands Heart Journal 6/2017 Go to the issue

Rhythm Puzzle - Question

Trompe l’oeil electrocardiogram